Stem Cells and Hyperbarics

Stem cells have the remarkable potential to develop into numerous different cell types and serve as the body’s primary internal repair system. The innate ability of stem cells to differentiate into other types of cells with specialized functions (blood, brain or tissue cells) replenishes and regenerates the body from the effects of aging and disease. Hyperbaric oxygen therapy (HBOT) has been shown to significantly increase the concentration of circulating stem/progenitor cells within the peripheral circulation system. By increasing blood plasma oxygen levels, bone marrow-derived stem cells were shown to significantly proliferate and mobilize. The proposed mechanism of action was through a nitric oxide-dependent mechanism. This evidence plays a key role in regenerative medicine as the increased number of stem cells in the body have the ability provide enhanced and accelerated physiological repair.

Studies have demonstrated HBOT’s therapeutic influence on stem cells with the following:

Enhance Stem Cell Activity with HBOT - Documented Physiological Effects:

  • Activates nitric oxide synthase type 3 (NOS-3)
  • Proliferates and mobilizes bone marrow-derived stem cells
  • Improves engraftment and differentiation of several progenitor cell types in organs such as the spleen, bone marrow, brain, peripheral nerve, pancreas, cartilage, and heart
  • Increase in colony-forming cells
  • Stimulation of stromal-derived growth factor
  • Reduces high ROS levels
  • Promotes endothelial growth factor-2 for angiogenesis
  • Increases CD34 expression and pluripotent stem cells

Enhance Healing from Disease/Injury with HBOT - Clinically Documented and Supported Through Research Citations:

  • Accelerates growth and repair of damaged tissue
  • Improves tissue regeneration and organ functionality
  • Promotes neurogenesis
  • Stimulates osteogenesis
  • Ameliorates diabetic symptoms
  • Enhances recovery from heart attack

Source: International Hyperbarics Association

Information on this website is provided for educational purposes only. It is not intended as a substitute for the diagnosis, treatment, and advice of a qualified licensed professional. This website offers general information and in no way should anyone consider that this website represents the practice of medicine. This website assumes no responsibility for how this information is used. Also note that this website frequently updates its contents, due to a variety of reasons. No statements or implied treatments on this website have been evaluated or approved by the FDA. It is important that you do not reduce, change, or discontinue any medication or treatment without first consulting your doctor. Please consult your doctor before beginning any new program of treatment.

Study: Stem Cells Mobilized with Hyperbaric Oxygen Therapy (HBOT)

A landmark study published in 2005 (Am J Physiol Heart Circ Physiol Nov. 2005) involved 26 patients who were at risk for osteoradionecrosis after undergoing radiation therapy for head or neck tumors. All patients underwent twenty (20) HBOT treatments and blood was collected and evaluated after the first, tenth, and twentieth treatments. The population of CD34 cells in the peripheral circulation system doubled after the first treatment and increased eight-fold by the end of the trial. Colony forming cells also significantly increased, while vascular endothelial growth factor-2 and stromal derived growth factor increased as well. The study concluded that HBOT mobilizes bone marrow-derived stem/progenitor cells by stimulating nitric oxide synthesis.

Read the full study: “Stem cell mobilization by hyperbaric oxygen.”